25 XP   0   0   10

RenovoRx Inc
Buy, Hold or Sell?

Let's analyse Renovorx together

PenkeI guess you are interested in RenovoRx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of RenovoRx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about RenovoRx Inc

I send you an email if I find something interesting about RenovoRx Inc.

Quick analysis of Renovorx (30 sec.)










What can you expect buying and holding a share of Renovorx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.13
Expected worth in 1 year
$-0.39
How sure are you?
7.1%

+ What do you gain per year?

Total Gains per Share
$-0.26
Return On Investment
-21.6%

For what price can you sell your share?

Current Price per Share
$1.21
Expected price per share
$1 - $1.26
How sure are you?
50%

1. Valuation of Renovorx (5 min.)




Live pricePrice per Share (EOD)

$1.21

Intrinsic Value Per Share

$-4.79 - $-5.61

Total Value Per Share

$-4.92 - $-5.74

2. Growth of Renovorx (5 min.)




Is Renovorx growing?

Current yearPrevious yearGrowGrow %
How rich?-$3m$6.9m-$8.1m-676.1%

How much money is Renovorx making?

Current yearPrevious yearGrowGrow %
Making money-$2.5m-$2.5m-$50.2k-2.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Renovorx (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#911 / 1010

Most Revenue
#829 / 1010

Most Profit
#331 / 1010

Most Efficient
#283 / 1010

What can you expect buying and holding a share of Renovorx? (5 min.)

Welcome investor! Renovorx's management wants to use your money to grow the business. In return you get a share of Renovorx.

What can you expect buying and holding a share of Renovorx?

First you should know what it really means to hold a share of Renovorx. And how you can make/lose money.

Speculation

The Price per Share of Renovorx is $1.21. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Renovorx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Renovorx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.13. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Renovorx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-11.1%-0.11-8.8%-0.10-7.9%-0.09-7.3%-0.09-7.3%
Usd Book Value Change Per Share0.000.0%-0.07-5.4%-0.10-8.0%-0.01-0.7%-0.01-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.07-5.4%-0.10-8.0%-0.01-0.7%-0.01-0.7%
Usd Price Per Share1.34-1.81-2.46-2.20-2.20-
Price to Earnings Ratio-2.49--4.54--6.43--6.14--6.14-
Price-to-Total Gains Ratio-23.79--25.30--24.60--24.60-
Price to Book Ratio-10.70-1,331.36-11.35-385.16-385.16-
Price-to-Total Gains Ratio-23.79--25.30--24.60--24.60-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.21
Number of shares826
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.07-0.01
Usd Total Gains Per Share-0.07-0.01
Gains per Quarter (826 shares)-53.94-7.39
Gains per Year (826 shares)-215.76-29.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-216-2260-30-40
20-432-4420-59-70
30-647-6580-89-100
40-863-8740-118-130
50-1079-10900-148-160
60-1295-13060-177-190
70-1510-15220-207-220
80-1726-17380-236-250
90-1942-19540-266-280
100-2158-21700-296-310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.014.00.00.0%0.014.00.00.0%0.014.00.00.0%
Book Value Change Per Share0.03.01.00.0%1.010.01.08.3%1.012.01.07.1%1.012.01.07.1%1.012.01.07.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share0.03.01.00.0%1.010.01.08.3%1.012.01.07.1%1.012.01.07.1%1.012.01.07.1%

Fundamentals of Renovorx

About RenovoRx Inc

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. The company was founded in 2009 and is headquartered in Los Altos, California.

Fundamental data was last updated by Penke on 2024-04-24 21:04:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of RenovoRx Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Renovorx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Renovorx to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RenovoRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.3%+282.3%
5Y--436.8%+436.8%
10Y--597.3%+597.3%
1.1.2. Return on Assets

Shows how efficient Renovorx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Renovorx to the Biotechnology industry mean.
  • -220.1% Return on Assets means that Renovorx generated $-2.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of RenovoRx Inc:

  • The MRQ is -220.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -129.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-220.1%TTM-129.4%-90.8%
TTM-129.4%YOY-36.4%-93.0%
TTM-129.4%5Y-64.5%-64.8%
5Y-64.5%10Y-64.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-220.1%-13.3%-206.8%
TTM-129.4%-12.8%-116.6%
YOY-36.4%-11.6%-24.8%
5Y-64.5%-13.8%-50.7%
10Y-64.5%-15.6%-48.9%
1.1.3. Return on Equity

Shows how efficient Renovorx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Renovorx to the Biotechnology industry mean.
  • 0.0% Return on Equity means Renovorx generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of RenovoRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-5,969.8%+5,969.8%
TTM-5,969.8%YOY-46.2%-5,923.6%
TTM-5,969.8%5Y-1,722.3%-4,247.5%
5Y-1,722.3%10Y-1,722.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM-5,969.8%-16.1%-5,953.7%
YOY-46.2%-14.9%-31.3%
5Y-1,722.3%-19.3%-1,703.0%
10Y-1,722.3%-20.1%-1,702.2%

1.2. Operating Efficiency of RenovoRx Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Renovorx is operating .

  • Measures how much profit Renovorx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Renovorx to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RenovoRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--288.4%+288.4%
5Y--486.2%+486.2%
10Y--628.4%+628.4%
1.2.2. Operating Ratio

Measures how efficient Renovorx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of RenovoRx Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.838-3.838
5Y-5.679-5.679
10Y-7.823-7.823

1.3. Liquidity of RenovoRx Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Renovorx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.25 means the company has $1.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of RenovoRx Inc:

  • The MRQ is 1.248. The company is just able to pay all its short-term debts.
  • The TTM is 2.101. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.248TTM2.101-0.853
TTM2.101YOY7.123-5.022
TTM2.1015Y6.726-4.625
5Y6.72610Y6.7260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2483.863-2.615
TTM2.1014.169-2.068
YOY7.1235.337+1.786
5Y6.7266.122+0.604
10Y6.7266.434+0.292
1.3.2. Quick Ratio

Measures if Renovorx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Renovorx to the Biotechnology industry mean.
  • A Quick Ratio of 1.00 means the company can pay off $1.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RenovoRx Inc:

  • The MRQ is 0.998. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.628. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.998TTM1.628-0.630
TTM1.628YOY9.795-8.167
TTM1.6285Y7.174-5.546
5Y7.17410Y7.1740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9983.504-2.506
TTM1.6283.991-2.363
YOY9.7955.371+4.424
5Y7.1746.088+1.086
10Y7.1746.395+0.779

1.4. Solvency of RenovoRx Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Renovorx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Renovorx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.05 means that Renovorx assets are financed with 304.6% credit (debt) and the remaining percentage (100% - 304.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of RenovoRx Inc:

  • The MRQ is 3.046. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.976. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.046TTM1.976+1.071
TTM1.976YOY0.164+1.812
TTM1.9765Y2.830-0.855
5Y2.83010Y2.8300.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0460.339+2.707
TTM1.9760.337+1.639
YOY0.1640.271-0.107
5Y2.8300.368+2.462
10Y2.8300.388+2.442
1.4.2. Debt to Equity Ratio

Measures if Renovorx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Renovorx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of RenovoRx Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM147.454-147.454
TTM147.454YOY0.206+147.247
TTM147.4545Y42.204+105.250
5Y42.20410Y42.2040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM147.4540.403+147.051
YOY0.2060.335-0.129
5Y42.2040.427+41.777
10Y42.2040.461+41.743

2. Market Valuation of RenovoRx Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Renovorx generates.

  • Above 15 is considered overpriced but always compare Renovorx to the Biotechnology industry mean.
  • A PE ratio of -2.49 means the investor is paying $-2.49 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RenovoRx Inc:

  • The EOD is -2.245. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.486. Based on the earnings, the company is expensive. -2
  • The TTM is -4.539. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.245MRQ-2.486+0.241
MRQ-2.486TTM-4.539+2.052
TTM-4.539YOY-6.431+1.893
TTM-4.5395Y-6.140+1.602
5Y-6.14010Y-6.1400.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.245-2.300+0.055
MRQ-2.486-2.656+0.170
TTM-4.539-2.718-1.821
YOY-6.431-4.145-2.286
5Y-6.140-6.258+0.118
10Y-6.140-6.315+0.175
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of RenovoRx Inc:

  • The EOD is -3.529. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.908. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.597. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.529MRQ-3.908+0.379
MRQ-3.908TTM-4.597+0.689
TTM-4.597YOY-6.407+1.810
TTM-4.5975Y-6.859+2.262
5Y-6.85910Y-6.8590.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.529-2.974-0.555
MRQ-3.908-3.306-0.602
TTM-4.597-3.508-1.089
YOY-6.407-5.613-0.794
5Y-6.859-8.378+1.519
10Y-6.859-8.873+2.014
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Renovorx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -10.70 means the investor is paying $-10.70 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of RenovoRx Inc:

  • The EOD is -9.660. Based on the equity, the company is expensive. -2
  • The MRQ is -10.698. Based on the equity, the company is expensive. -2
  • The TTM is 1,331.364. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.660MRQ-10.698+1.038
MRQ-10.698TTM1,331.364-1,342.061
TTM1,331.364YOY11.347+1,320.016
TTM1,331.3645Y385.160+946.204
5Y385.16010Y385.1600.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.6601.914-11.574
MRQ-10.6982.116-12.814
TTM1,331.3642.097+1,329.267
YOY11.3472.881+8.466
5Y385.1603.550+381.610
10Y385.1603.936+381.224
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of RenovoRx Inc.

3.1. Institutions holding RenovoRx Inc

Institutions are holding 1.964% of the shares of RenovoRx Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Watch Point Trust Co0.57610.02597165971650
2023-12-31Vanguard Group Inc0.3355056578-18155-24.2932
2023-12-31Geode Capital Management, LLC0.330605575900
2023-12-31Charles Schwab Investment Management Inc0.291904923200
2023-12-31BlackRock Inc0.1268021388605439.4809
2023-12-31State Street Corporation0.111801885200
2023-12-31HRT FINANCIAL LLC0.08330.000214041140410
2024-03-31Affinity Capital Advisors, LLC0.07870.0041327900
2023-12-31Tower Research Capital LLC0.02730.000145992390108.1938
2023-12-31Bank of America Corp0.000701181180
2023-12-31Royal Bank of Canada0.000601011010
2023-12-31Wells Fargo & Co0.000406769.8361
2023-12-31Ground Swell Capital, LLC000-11481-100
2023-12-31Susquehanna International Group, LLP000-10340-100
2023-12-31Level Four Advisory Services, LLC000-15000-100
2023-12-31Morgan Stanley - Brokerage Accounts000-176-100
2023-12-31JPMorgan Chase & Co000-9-100
2023-12-31COHEN LAWRENCE B000-97165-100
Total 1.96370.0293331179-32451-9.8%

3.2. Funds holding RenovoRx Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.33640.0001567371590.281
2024-02-29Fidelity Extended Market Index0.29650.000250004-242-0.4816
2024-03-31Schwab Total Stock Market Index0.29190.00034923200
2024-03-28iShares Micro-Cap ETF0.12360.0032084000
2024-02-29Fidelity Series Total Market Index0.067501137900
2024-03-31NT Ext Equity Mkt Idx Fd - L0.02920.0001492500
2023-12-31Northern Trust Extended Eq Market Idx0.02920.0002492500
2024-02-29Fidelity Nasdaq Composite Index0.02250379400
2024-02-29Spartan Extended Market Index Pool E0.0110.0001185524215.0031
2024-03-31State St US Extended Mkt Indx NL Cl C0.00470.000180000
2023-12-31SSgA U.S. Extended Market Index Class I0.00470.000180000
2023-12-31SSgA U.S. Total Market Index Strategy0.00140231-5-2.1186
2024-02-29Fidelity U.S. Equity Index Ins Trust0.0003056560
Total 1.21890.0042205578+210+0.1%

3.3. Insider Transactions

Insiders are holding 9.785% of the shares of RenovoRx Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-10-03Angela NelmsBUY11001.05

4. Summary

4.1. Key Performance Indicators

The key performance indicators of RenovoRx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.0650%-0.0970%-0.0090%-0.0090%
Book Value Per Share---0.125-0.050-60%0.289-143%0.062-301%0.062-301%
Current Ratio--1.2482.101-41%7.123-82%6.726-81%6.726-81%
Debt To Asset Ratio--3.0461.976+54%0.164+1755%2.830+8%2.830+8%
Debt To Equity Ratio---147.454-100%0.206-100%42.204-100%42.204-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.135-0.106-21%-0.096-29%-0.088-34%-0.088-34%
Free Cash Flow Per Share---0.086-0.100+17%-0.098+15%-0.084-3%-0.084-3%
Free Cash Flow To Equity Per Share---0.086-0.048-44%-0.098+14%-0.009-89%-0.009-89%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.613--------
Intrinsic Value_10Y_min---4.791--------
Intrinsic Value_1Y_max---0.392--------
Intrinsic Value_1Y_min---0.385--------
Intrinsic Value_3Y_max---1.308--------
Intrinsic Value_3Y_min---1.246--------
Intrinsic Value_5Y_max---2.380--------
Intrinsic Value_5Y_min---2.198--------
Market Cap28979258.000-11%32092732.00043229389.000-26%58886570.750-46%52800755.500-39%52800755.500-39%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-9.660+10%-10.6981331.364-101%11.347-194%385.160-103%385.160-103%
Pe Ratio-2.245+10%-2.486-4.539+83%-6.431+159%-6.140+147%-6.140+147%
Price Per Share1.210-11%1.3401.805-26%2.459-46%2.205-39%2.205-39%
Price To Free Cash Flow Ratio-3.529+10%-3.908-4.597+18%-6.407+64%-6.859+76%-6.859+76%
Quick Ratio--0.9981.628-39%9.795-90%7.174-86%7.174-86%
Return On Assets---2.201-1.294-41%-0.364-83%-0.645-71%-0.645-71%
Return On Equity----59.6980%-0.4620%-17.2230%-17.2230%
Total Gains Per Share----0.0650%-0.0970%-0.0090%-0.0090%
Usd Book Value---3000000.000-1201500.000-60%6921750.000-143%1488928.571-301%1488928.571-301%
Usd Book Value Change Per Share----0.0650%-0.0970%-0.0090%-0.0090%
Usd Book Value Per Share---0.125-0.050-60%0.289-143%0.062-301%0.062-301%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.135-0.106-21%-0.096-29%-0.088-34%-0.088-34%
Usd Free Cash Flow---2053000.000-2401250.000+17%-2355000.000+15%-2000571.429-3%-2000571.429-3%
Usd Free Cash Flow Per Share---0.086-0.100+17%-0.098+15%-0.084-3%-0.084-3%
Usd Free Cash Flow To Equity Per Share---0.086-0.048-44%-0.098+14%-0.009-89%-0.009-89%
Usd Market Cap28979258.000-11%32092732.00043229389.000-26%58886570.750-46%52800755.500-39%52800755.500-39%
Usd Price Per Share1.210-11%1.3401.805-26%2.459-46%2.205-39%2.205-39%
Usd Profit---3227000.000-2550500.000-21%-2500250.000-23%-2171857.143-33%-2171857.143-33%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share----0.0650%-0.0970%-0.0090%-0.0090%
 EOD+1 -6MRQTTM+6 -17YOY+8 -155Y+3 -2010Y+3 -20

4.2. Fundamental Score

Let's check the fundamental score of RenovoRx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.245
Price to Book Ratio (EOD)Between0-1-9.660
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.998
Current Ratio (MRQ)Greater than11.248
Debt to Asset Ratio (MRQ)Less than13.046
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.201
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of RenovoRx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.235
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,466
Total Liabilities4,466
Total Stockholder Equity-3,000
 As reported
Total Liabilities 4,466
Total Stockholder Equity+ -3,000
Total Assets = 1,466

Assets

Total Assets1,466
Total Current Assets1,466
Long-term Assets101
Total Current Assets
Cash And Cash Equivalents 1,173
Other Current Assets 192
Total Current Assets  (as reported)1,466
Total Current Assets  (calculated)1,365
+/- 101
Long-term Assets
Long-term Assets Other 101
Long-term Assets  (as reported)101
Long-term Assets  (calculated)101
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,175
Long-term Liabilities3,291
Total Stockholder Equity-3,000
Total Current Liabilities
Accounts payable 561
Other Current Liabilities 614
Total Current Liabilities  (as reported)1,175
Total Current Liabilities  (calculated)1,175
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)3,291
Long-term Liabilities  (calculated)0
+/- 3,291
Total Stockholder Equity
Common Stock1
Retained Earnings -41,405
Other Stockholders Equity 38,404
Total Stockholder Equity (as reported)-3,000
Total Stockholder Equity (calculated)-3,000
+/-0
Other
Cash and Short Term Investments 1,173
Common Stock Shares Outstanding 10,694
Liabilities and Stockholders Equity 1,466
Net Debt -1,173
Net Working Capital 291



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
1,914
1,278
2,164
18,178
16,287
13,946
11,243
9,250
7,265
4,561
6,314
3,519
1,466
1,466
1,4661,4663,5196,3144,5617,2659,25011,24313,94616,28718,1782,1641,2781,914000
   > Total Current Assets 
0
0
0
1,910
953
1,725
18,164
16,281
13,943
11,243
9,250
7,265
4,561
6,314
3,519
1,466
1,466
1,4661,4663,5196,3144,5617,2659,25011,24313,94316,28118,1641,7259531,910000
       Cash And Cash Equivalents 
0
0
0
1,795
837
1,557
17,725
15,192
13,121
2,769
3,093
4,391
3,723
5,954
3,226
1,173
1,173
1,1731,1733,2265,9543,7234,3913,0932,76913,12115,19217,7251,5578371,795000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
7,996
5,021
2,049
0
0
0
0
0
000002,0495,0217,996000000000
       Other Current Assets 
0
0
0
115
116
168
439
1,089
822
478
1,136
825
592
324
252
192
192
1921922523245928251,1364788221,089439168116115000
   > Long-term Assets 
0
0
0
4
325
439
14
6
3
0
6
0
246
36
41
0
101
1010413624606036144393254000
       Property Plant Equipment 
0
0
0
0
0
15
10
6
3
0
0
0
0
0
0
0
0
0000000036101500000
       Other Assets 
0
0
0
0
325
424
4
0
0
0
-6
0
-246
-36
-41
0
-101
-1010-41-36-2460-600044243250000
> Total Liabilities 
0
0
0
16,570
17,040
19,224
625
938
1,406
1,123
1,102
1,102
1,305
5,126
3,513
4,466
4,466
4,4664,4663,5135,1261,3051,1021,1021,1231,40693862519,22417,04016,570000
   > Total Current Liabilities 
0
0
0
4,096
4,589
6,773
625
938
1,406
1,123
1,102
1,102
1,305
1,699
1,605
1,175
1,175
1,1751,1751,6051,6991,3051,1021,1021,1231,4069386256,7734,5894,096000
       Short-term Debt 
0
0
0
2,767
2,843
4,801
0
0
0
0
0
0
0
0
0
0
0
000000000004,8012,8432,767000
       Short Long Term Debt 
0
0
0
2,767
2,843
4,801
0
0
0
0
0
0
0
0
0
0
0
000000000004,8012,8432,767000
       Accounts payable 
0
0
0
162
472
263
133
525
729
473
538
534
828
872
350
561
561
561561350872828534538473729525133263472162000
       Other Current Liabilities 
0
0
0
856
861
1,271
492
413
677
650
564
568
477
827
1,255
0
614
61401,2558274775685646506774134921,271861856000
   > Long-term Liabilities 
0
0
0
12,474
12,451
12,451
133
525
729
650
538
568
477
3,427
1,908
3,291
3,291
3,2913,2911,9083,42747756853865072952513312,45112,45112,474000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,427
0
0
0
0003,4270000000000000
       Deferred Long Term Liability 
0
0
0
0
321
420
0
0
0
0
0
0
0
36
0
0
0
0003600000004203210000
> Total Stockholder Equity
0
0
0
-14,656
-15,762
-17,060
17,553
15,349
12,540
10,120
8,148
6,163
3,256
1,188
6
-3,000
-3,000
-3,000-3,00061,1883,2566,1638,14810,12012,54015,34917,553-17,060-15,762-14,656000
   Common Stock
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
0
1
10111111111111000
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-18,178
0
0
-4
13
17
0
0
0
0
0
000001713-400-18,178000000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
303
345
357
36,481
36,632
36,826
37,004
37,151
37,318
37,685
37,944
38,183
0
38,404
38,404038,18337,94437,68537,31837,15137,00436,82636,63236,481357345303000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-11,396
Operating Income-11,396-11,396
 
Operating Expense (+$)
Research Development5,667
Selling General Administrative6
Selling And Marketing Expenses5,723
Operating Expense11,39611,396
 
Net Interest Income (+$)
Interest Income111
Interest Expense-108
Other Finance Cost-108
Net Interest Income111
 
Pretax Income (+$)
Operating Income-11,396
Net Interest Income111
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,232-12,560
EBIT - interestExpense = -11,504
-10,232
-10,124
Interest Expense108
Earnings Before Interest and Taxes (EBIT)-11,396-10,124
Earnings Before Interest and Taxes (EBITDA)-11,396
 
After tax Income (+$)
Income Before Tax-10,232
Tax Provision-0
Net Income From Continuing Ops-9,161-10,232
Net Income-10,232
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses11,396
Total Other Income/Expenses Net1,164-111
 

Technical Analysis of Renovorx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Renovorx. The general trend of Renovorx is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Renovorx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of RenovoRx Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.26 < 1.26 < 1.26.

The bearish price targets are: 1.1 > 1.03 > 1.

Tweet this
RenovoRx Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of RenovoRx Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

RenovoRx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of RenovoRx Inc.

RenovoRx Inc Daily Moving Average Convergence/Divergence (MACD) ChartRenovoRx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of RenovoRx Inc. The current adx is .

RenovoRx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of RenovoRx Inc.

RenovoRx Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of RenovoRx Inc.

RenovoRx Inc Daily Relative Strength Index (RSI) ChartRenovoRx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of RenovoRx Inc.

RenovoRx Inc Daily Stochastic Oscillator ChartRenovoRx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of RenovoRx Inc.

RenovoRx Inc Daily Commodity Channel Index (CCI) ChartRenovoRx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of RenovoRx Inc.

RenovoRx Inc Daily Chande Momentum Oscillator (CMO) ChartRenovoRx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of RenovoRx Inc.

RenovoRx Inc Daily Williams %R ChartRenovoRx Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of RenovoRx Inc.

RenovoRx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of RenovoRx Inc.

RenovoRx Inc Daily Average True Range (ATR) ChartRenovoRx Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of RenovoRx Inc.

RenovoRx Inc Daily On-Balance Volume (OBV) ChartRenovoRx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of RenovoRx Inc.

RenovoRx Inc Daily Money Flow Index (MFI) ChartRenovoRx Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for RenovoRx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

RenovoRx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of RenovoRx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.235
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Renovorx with someone you think should read this too:
  • Are you bullish or bearish on Renovorx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Renovorx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about RenovoRx Inc

I send you an email if I find something interesting about RenovoRx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about RenovoRx Inc.

Receive notifications about RenovoRx Inc in your mailbox!